INGELHEIM, Germany and INDIANAPOLIS--(BUSINESS WIRE)--For Non-US and Non-UK Media. More than 40 presentations including posters, abstracts and oral presentations will demonstrate the breadth and depth of the Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) diabetes portfolio at the American Diabetes Association’s (ADA) 74th Scientific Sessions® in San Francisco, 13-17 June.
Help employers find you! Check out all the jobs and post your resume.
